PrestonS.GableMD

Oncology • San Diego, CA

Hematologic Oncology

Hematology/Oncology at Naval Medical Center, San Diego

Join to view full profile

Dr. Gable is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Gable's full profile

Already have an account?

Office
34730 Bob Wilson Dr
Ste 202
San Diego, CA 92134
Phone+1 619-532-7300

Fax+1 619-532-9196
Is this information wrong?

Education & Training

Naval Medical Center (San Diego)Fellowship, Hematology and Medical Oncology, 1992 - 1995
Naval Medical Center (San Diego)Residency, Internal Medicine, 1989 - 1992
Naval Medical Center (San Diego)Internship, Internal Medicine, 1989 - 1990
University of Minnesota Medical SchoolClass of 1989

Certifications & Licensure

CA State Medical License 1992 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Master Clinician Naval Medical Center San Diego, 2015

Clinical Trials

Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia Start of enrollment: 1999 Apr 01
Active, not recruiting
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma Start of enrollment: 1984 Jun 01
Active, not recruiting
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Start of enrollment: 2005 May 01
Completed
Phase 3
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Start of enrollment: 2007 May 08
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2008 Mar 12
Active, not recruiting
Phase 2
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13
Completed
Phase 3
Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes Start of enrollment: 1996 May 01
Active, not recruiting
Join now to see all

Publications & Presentations

PubMed

384 citations
Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583).
Eric J. Small, Susan Halabi, Nancy A. Dawson, Walter M. Stadler, Brian I. Rini
Journal of Clinical Oncology. 2004-03-15
1 citations
Diagnosis of Rosai-Dorfman Disease by Upper Endoscopic Ultrasound-Guided Fine-Needle Biopsy.
Austin Gable, Thomas Mellor, Andrew Peacock, Devon Mahoney, Preston Gable
ACG Case Reports Journal. 2022-06-01
109 citations
Randomized, Phase III Study of Weekly Paclitaxel in Combination With Carboplatin Versus Standard Every-3-Weeks Administration of Carboplatin and Paclitaxel for Patient...
Chandra P. Belani, Suresh S. Ramalingam, Michael C. Perry, Renato V. LaRocca, David Rinaldi
Journal of Clinical Oncology. 2008-01-20

Press Mentions

NMCSD Recognizes Providers Receiving 100% Patient SatisfactionAugust 13th, 2024
Download Clinical Vignette and Research Abstract CompendiumJanuary 16th, 2018

Hospital Affiliations

Naval Medical Center San DiegoSan Diego, California